Global Epinephrine Autoinjector Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
According to our (Global Info Research) latest study, the global Epinephrine Autoinjector market size was valued at USD 2223.6 million in 2022 and is forecast to a readjusted size of USD 3500.8 million by 2029 with a CAGR of 6.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Epinephrine Autoinjector key players include Mylan, Amneal pharma, Kaleo, etc. Global top three players hold a share about 25%.
North America is the largest market, with a share about 70%, followed by Europe and Asia-Pacific, having a total share about 25 percent. 
In terms of product, 0.15 mg is the largest segment, with a share about 65%. And in terms of application, the largest application is people who are Under 6 Years, followed by people who are 6 to 12 Years and Over 12 Years.
This report is a detailed and comprehensive analysis for global Epinephrine Autoinjector market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Epinephrine Autoinjector market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Epinephrine Autoinjector market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Epinephrine Autoinjector market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Epinephrine Autoinjector market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epinephrine Autoinjector
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epinephrine Autoinjector market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mylan, Sanofi, ALK Abello and Impax, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Epinephrine Autoinjector market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    0.30 mg
    0.15 mg
Market segment by Application
    Under 6 Years
    6 to 12 Years
    Over 12 Years
Major players covered
    Mylan
    Sanofi
    ALK Abello
    Impax
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epinephrine Autoinjector product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Epinephrine Autoinjector, with price, sales, revenue and global market share of Epinephrine Autoinjector from 2018 to 2023.
Chapter 3, the Epinephrine Autoinjector competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epinephrine Autoinjector breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Epinephrine Autoinjector market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Epinephrine Autoinjector.
Chapter 14 and 15, to describe Epinephrine Autoinjector sales channel, distributors, customers, research findings and conclusion.